December 30th, 2008
Salix asks FDA to talk dispute over (The News & Observer)
Salix Pharmaceuticals has asked for a hearing with the Food and Drug Administration to resolve disagreements over approval of a new tablet for the bowel disorder ulcerative colitis.
Filed under: Colitis
Leave a Reply